<DOC>
	<DOCNO>NCT02861911</DOCNO>
	<brief_summary>Facioscapulohumeral muscular dystrophy ( FSHD ) autosomal dominant disease characterize progressive weakness atrophy specific skeletal muscle . One major problem patient affect FSHD limitation perform daily activity induce progressive muscle weakness . This sedentary lifestyle cause `` debilitative cycle , '' neuromuscular deconditioning even aggravate muscular deficiency . Recent study indicate safety effectiveness moderate aerobic training program patient FSHD . However , train program limited applicability patient severe muscular weakness . Artificial strength training mean neuromuscular electrical stimulation ( NMES ) appear promising rehabilitation strategy FSHD patient suffer neuromuscular disorder . Therefore propose investigate feasibility , safety , effectiveness NMES strength training counteract quadriceps muscle weakness patient affect FSHD .</brief_summary>
	<brief_title>Effects NMES Muscle Function Patients With FSHD : Double-blind Randomized Controled Clinical Trial</brief_title>
	<detailed_description>NMES deliver quadriceps mean Kneehab® XP device , innovative clinically-proven garment-based product design specifically treat quadriceps muscle atrophy . The main NMES current parameter : 50-Hz frequency , 100-400 µs pulse duration , 5:10-second : time . Each session last approximately 20 minute repeat 5 days/week total duration treatment program 3 month .</detailed_description>
	<criteria>Molecular and/or clinical diagnosis FSHD Vignos scale ≤ 5 : Able walk without help Clinically characterize quadriceps muscle weakness maximal voluntary contraction ( MVC ) 8 16 Kg Follow part usual care Clinical Physiology Department University Hospital Montpellier Free inform consent patient Patient affiliate beneficiary social security system Patient comorbidity : pathology heart , pathology respiratory , metabolic endocrine pathology , pathology cancer . Patients treat drug could cause muscle side effect interfere muscle metabolism . Lesions skin inflammation thigh prevent application NMES Claustrophobic subject Carrier intracranial vascular clip , cardiac pacemaker , neurostimulator , cochlear implant , intraocular metallic foreign Pregnant nursing woman Vulnerable Persons protect Major unable consent Patient exclusion period relative another protocol , annual amount maximum compensation € 4,500 reach</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Muscle function</keyword>
	<keyword>Oxidative stress</keyword>
	<keyword>Quality life</keyword>
	<keyword>Physical activity</keyword>
</DOC>